COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020

NACompletedINTERVENTIONAL
Enrollment

2,817

Participants

Timeline

Start Date

June 20, 2020

Primary Completion Date

October 31, 2020

Study Completion Date

December 31, 2020

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

Serological tests for SARS Cov-2

Each participant will have a blood test on a dry tube of maximum 8 ml of whole blood

Trial Locations (1)

6060

Grand Hôpital de Charleroi, Charleroi

All Listed Sponsors
lead

Grand Hôpital de Charleroi

OTHER

NCT04723290 - COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020 | Biotech Hunter | Biotech Hunter